177 related articles for article (PubMed ID: 20031622)
1. Genetic variation at the proprotein convertase subtilisin/kexin type 5 gene modulates high-density lipoprotein cholesterol levels.
Iatan I; Dastani Z; Do R; Weissglas-Volkov D; Ruel I; Lee JC; Huertas-Vazquez A; Taskinen MR; Prat A; Seidah NG; Pajukanta P; Engert JC; Genest J
Circ Cardiovasc Genet; 2009 Oct; 2(5):467-75. PubMed ID: 20031622
[TBL] [Abstract][Full Text] [Related]
2. Intake levels of dietary polyunsaturated fatty acids modify the association between the genetic variation in PCSK5 and HDL cholesterol.
Jang HB; Hwang JY; Park JE; Oh JH; Ahn Y; Kang JH; Park KH; Han BG; Kim BJ; Park SI; Lee HJ
J Med Genet; 2014 Dec; 51(12):782-8. PubMed ID: 25351954
[TBL] [Abstract][Full Text] [Related]
3. From lipoprotein apheresis to proprotein convertase subtilisin/kexin type 9 inhibitors: Impact on low-density lipoprotein cholesterol and C-reactive protein levels in cardiovascular disease patients.
Zenti MG; Altomari A; Lupo MG; Botta M; Bonora E; Corsini A; Ruscica M; Ferri N
Eur J Prev Cardiol; 2018 Nov; 25(17):1843-1851. PubMed ID: 30058841
[TBL] [Abstract][Full Text] [Related]
4. The rs508487, rs236911, and rs236918 Genetic Variants of the Proprotein Convertase Subtilisin-Kexin Type 7 (
Vargas-Alarcón G; Pérez-Méndez O; González-Pacheco H; Ramírez-Bello J; Posadas-Sánchez R; Escobedo G; Fragoso JM
Cells; 2021 Jun; 10(6):. PubMed ID: 34207761
[TBL] [Abstract][Full Text] [Related]
5. A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis.
Chen SN; Ballantyne CM; Gotto AM; Tan Y; Willerson JT; Marian AJ
J Am Coll Cardiol; 2005 May; 45(10):1611-9. PubMed ID: 15893176
[TBL] [Abstract][Full Text] [Related]
6. Effect of an siRNA Therapeutic Targeting PCSK9 on Atherogenic Lipoproteins: Prespecified Secondary End Points in ORION 1.
Ray KK; Stoekenbroek RM; Kallend D; Leiter LA; Landmesser U; Wright RS; Wijngaard P; Kastelein JJP
Circulation; 2018 Sep; 138(13):1304-1316. PubMed ID: 29735484
[TBL] [Abstract][Full Text] [Related]
7. The proprotein convertase subtilisin/kexin type 9 gene E670G polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and Han populations.
Aung LH; Yin RX; Miao L; Hu XJ; Yan TT; Cao XL; Wu DF; Li Q; Pan SL; Wu JZ
Lipids Health Dis; 2011 Jan; 10():5. PubMed ID: 21232153
[TBL] [Abstract][Full Text] [Related]
8. Several genetic polymorphisms interact with overweight/obesity to influence serum lipid levels.
Yin RX; Wu DF; Miao L; Aung LH; Cao XL; Yan TT; Long XJ; Liu WY; Zhang L; Li M
Cardiovasc Diabetol; 2012 Oct; 11():123. PubMed ID: 23039238
[TBL] [Abstract][Full Text] [Related]
9. Association between the DOCK7, PCSK9 and GALNT2 Gene Polymorphisms and Serum Lipid levels.
Guo T; Yin RX; Huang F; Yao LM; Lin WX; Pan SL
Sci Rep; 2016 Jan; 6():19079. PubMed ID: 26744084
[TBL] [Abstract][Full Text] [Related]
10. Proprotein convertase subtilisin/kexin type 9 gene E670G polymorphism interacts with alcohol consumption to modulate serum lipid levels.
Aung LH; Yin RX; Wu DF; Cao XL; Hu XJ; Miao L
Int J Med Sci; 2013; 10(2):124-32. PubMed ID: 23329883
[TBL] [Abstract][Full Text] [Related]
11. Association of endothelial lipase gene (LIPG) haplotypes with high-density lipoprotein cholesterol subfractions and apolipoprotein AI plasma levels in Japanese Americans.
Hutter CM; Austin MA; Farin FM; Viernes HM; Edwards KL; Leonetti DL; McNeely MJ; Fujimoto WY
Atherosclerosis; 2006 Mar; 185(1):78-86. PubMed ID: 16023652
[TBL] [Abstract][Full Text] [Related]
12. Associations of lipoprotein lipase gene polymorphisms with longitudinal plasma lipid trends in young adults: The Coronary Artery Risk Development in Young Adults (CARDIA) study.
Tang W; Apostol G; Schreiner PJ; Jacobs DR; Boerwinkle E; Fornage M
Circ Cardiovasc Genet; 2010 Apr; 3(2):179-86. PubMed ID: 20150529
[TBL] [Abstract][Full Text] [Related]
13. Low-Density Lipoprotein Receptor-Dependent and Low-Density Lipoprotein Receptor-Independent Mechanisms of Cyclosporin A-Induced Dyslipidemia.
Kockx M; Glaros E; Leung B; Ng TW; Berbée JF; Deswaerte V; Nawara D; Quinn C; Rye KA; Jessup W; Rensen PC; Meikle PJ; Kritharides L
Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1338-49. PubMed ID: 27150391
[TBL] [Abstract][Full Text] [Related]
14. Multiancestry Genome-Wide Association Study of Lipid Levels Incorporating Gene-Alcohol Interactions.
de Vries PS; Brown MR; Bentley AR; Sung YJ; Winkler TW; Ntalla I; Schwander K; Kraja AT; Guo X; Franceschini N; Cheng CY; Sim X; Vojinovic D; Huffman JE; Musani SK; Li C; Feitosa MF; Richard MA; Noordam R; Aschard H; Bartz TM; Bielak LF; Deng X; Dorajoo R; Lohman KK; Manning AK; Rankinen T; Smith AV; Tajuddin SM; Evangelou E; Graff M; Alver M; Boissel M; Chai JF; Chen X; Divers J; Gandin I; Gao C; Goel A; Hagemeijer Y; Harris SE; Hartwig FP; He M; Horimoto ARVR; Hsu FC; Jackson AU; Kasturiratne A; Komulainen P; Kühnel B; Laguzzi F; Lee JH; Luan J; Lyytikäinen LP; Matoba N; Nolte IM; Pietzner M; Riaz M; Said MA; Scott RA; Sofer T; Stančáková A; Takeuchi F; Tayo BO; van der Most PJ; Varga TV; Wang Y; Ware EB; Wen W; Yanek LR; Zhang W; Zhao JH; Afaq S; Amin N; Amini M; Arking DE; Aung T; Ballantyne C; Boerwinkle E; Broeckel U; Campbell A; Canouil M; Charumathi S; Chen YI; Connell JM; de Faire U; de Las Fuentes L; de Mutsert R; de Silva HJ; Ding J; Dominiczak AF; Duan Q; Eaton CB; Eppinga RN; Faul JD; Fisher V; Forrester T; Franco OH; Friedlander Y; Ghanbari M; Giulianini F; Grabe HJ; Grove ML; Gu CC; Harris TB; Heikkinen S; Heng CK; Hirata M; Hixson JE; Howard BV; Ikram MA; ; Jacobs DR; Johnson C; Jonas JB; Kammerer CM; Katsuya T; Khor CC; Kilpeläinen TO; Koh WP; Koistinen HA; Kolcic I; Kooperberg C; Krieger JE; Kritchevsky SB; Kubo M; Kuusisto J; Lakka TA; Langefeld CD; Langenberg C; Launer LJ; Lehne B; Lemaitre RN; Li Y; Liang J; Liu J; Liu K; Loh M; Louie T; Mägi R; Manichaikul AW; McKenzie CA; Meitinger T; Metspalu A; Milaneschi Y; Milani L; Mohlke KL; Mosley TH; Mukamal KJ; Nalls MA; Nauck M; Nelson CP; Sotoodehnia N; O'Connell JR; Palmer ND; Pazoki R; Pedersen NL; Peters A; Peyser PA; Polasek O; Poulter N; Raffel LJ; Raitakari OT; Reiner AP; Rice TK; Rich SS; Robino A; Robinson JG; Rose LM; Rudan I; Schmidt CO; Schreiner PJ; Scott WR; Sever P; Shi Y; Sidney S; Sims M; Smith BH; Smith JA; Snieder H; Starr JM; Strauch K; Tan N; Taylor KD; Teo YY; Tham YC; Uitterlinden AG; van Heemst D; Vuckovic D; Waldenberger M; Wang L; Wang Y; Wang Z; Wei WB; Williams C; Wilson G; Wojczynski MK; Yao J; Yu B; Yu C; Yuan JM; Zhao W; Zonderman AB; Becker DM; Boehnke M; Bowden DW; Chambers JC; Deary IJ; Esko T; Farrall M; Franks PW; Freedman BI; Froguel P; Gasparini P; Gieger C; Horta BL; Kamatani Y; Kato N; Kooner JS; Laakso M; Leander K; Lehtimäki T; ; Magnusson PKE; Penninx B; Pereira AC; Rauramaa R; Samani NJ; Scott J; Shu XO; van der Harst P; Wagenknecht LE; Wang YX; Wareham NJ; Watkins H; Weir DR; Wickremasinghe AR; Zheng W; Elliott P; North KE; Bouchard C; Evans MK; Gudnason V; Liu CT; Liu Y; Psaty BM; Ridker PM; van Dam RM; Kardia SLR; Zhu X; Rotimi CN; Mook-Kanamori DO; Fornage M; Kelly TN; Fox ER; Hayward C; van Duijn CM; Tai ES; Wong TY; Liu J; Rotter JI; Gauderman WJ; Province MA; Munroe PB; Rice K; Chasman DI; Cupples LA; Rao DC; Morrison AC
Am J Epidemiol; 2019 Jun; 188(6):1033-1054. PubMed ID: 30698716
[TBL] [Abstract][Full Text] [Related]
15. Low Low-Density Lipoprotein Levels Are Associated With, But Do Not Causally Contribute to, Increased Mortality in Sepsis.
Walley KR; Boyd JH; Kong HJ; Russell JA
Crit Care Med; 2019 Mar; 47(3):463-466. PubMed ID: 30394916
[TBL] [Abstract][Full Text] [Related]
16. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol.
Guerra R; Wang J; Grundy SM; Cohen JC
Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4532-7. PubMed ID: 9114024
[TBL] [Abstract][Full Text] [Related]
17. Association of hepatic lipase gene polymorphisms with hypertriglyceridemia and low high-density lipoprotein-cholesterol levels among South Indian subjects without diabetes.
Ayyappa KA; Ghosh S; Mohan V; Radha V
Diabetes Technol Ther; 2013 Jun; 15(6):503-12. PubMed ID: 23550552
[TBL] [Abstract][Full Text] [Related]
18. Plasma proprotein convertase subtilisin kexin type 9 is not altered in subjects with impaired glucose metabolism and type 2 diabetes mellitus, but its relationship with non-HDL cholesterol and apolipoprotein B may be modified by type 2 diabetes mellitus: The CODAM study.
Brouwers MC; Troutt JS; van Greevenbroek MM; Ferreira I; Feskens EJ; van der Kallen CJ; Schaper NC; Schalkwijk CG; Konrad RJ; Stehouwer CD
Atherosclerosis; 2011 Jul; 217(1):263-7. PubMed ID: 21497351
[TBL] [Abstract][Full Text] [Related]
19. ABO blood group in relation to plasma lipids and proprotein convertase subtilisin/kexin type 9.
Li S; Xu RX; Guo YL; Zhang Y; Zhu CG; Sun J; Li JJ
Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):411-7. PubMed ID: 25466598
[TBL] [Abstract][Full Text] [Related]
20. LIPC variants in the promoter and intron 1 modify HDL-C levels in a sex-specific fashion.
Feitosa MF; Myers RH; Pankow JS; Province MA; Borecki IB
Atherosclerosis; 2009 May; 204(1):171-7. PubMed ID: 19101670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
